Conditions: HIV Infections Heart Disease
Keywords: Omega-3 Fatty Acids HIV Heart Disease Treatment experienced
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 35
Healthy volunteers: no

Brief summary:
Several studies have shown that there is an increased risk of heart disease in people with HIV. In this study the investigators are looking at the effect of Lovaza (Omega-3 fatty acid) on improving endothelial function and decreasing inflammation which may contribute to this increased risk. The investigators will also be doing studies to analyze coagulation and inflammation markers.

Detailed description:

Arms:
arm 1: Lovaza 1 gram by mouth twice a day for 24 weeks. arm 2: Placebo capsule by mouth twice a day x 24 weeks.

Interventions: intervention 1: Lovaza intervention 2: Placebo
Intervention descriptions: intervention 1: Lovaza one gram twice a day for 24 weeks intervention 2: Placebo

Protocol document: